NASDAQ:MGNX
Macrogenics Inc.
Macrogenics Inc.'s revenue fell 0.3% in fiscal 2025 to $149.5M while operating margin rose to −48.7%. Free cash flow was −$83.0M, −55.5% of revenue, and the diluted share count rose 0.9%.Summary generated from Macrogenics Inc.'s SEC filings. Latest annual report filed Mar 9, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$149.5M
Revenue growth−0.3%
Revenue, 5-yr CAGR+7.3%
Gross margin100.0%
Operating margin−48.7%
Net margin−49.9%
ROICn/a
Return on equity−86.9%
Debt / equityn/a
Free cash flow−$83.0M
FCF margin−55.5%
Share count change+0.9%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 77 | 152 | 59 | 150 | 150 |
| Operating income | −203 | −121 | −168 | −111 | −73 |
| Net income | −202 | −120 | −9 | −67 | −75 |
| Free cash flow | −150 | −91 | −80 | −72 | −83 |
Recent filings
- 4Insider transaction report
Oct 7, 2026 - 8-K/AAmended current report
Sep 3, 2026 - 4Insider transaction report
Aug 20, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 14, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 8-KOther events
Jul 23, 2026 - 8-KDirector or officer change
Jul 8, 2026 - 8-KCompletion of an acquisition or disposition
Jul 7, 2026